EIF5A2 and ovarian carcinoma: In ovarian cancer, Guan et al. studied the correlation between the reduction of eIF-5A2 copy number and cell growth rate and showed that the cell growth rate was inhibited when the eIF-5A2 copy number of DMs was reduced.250 Yu et al. found that gemcitabine is able to decrease the number of DMs in the ovarian cancer cell line UACC-1598.